Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vidrio Technologies is a life science research tools company focused on software and hardware for laser scanning, multiphoton, and confocal microscopy. The company is best known for ScanImage, a widely used MATLAB-based microscope control software package, and for vDAQ, a data acquisition and microscope control hardware platform. Its products are used primarily by neuroscience and other biological research laboratories to enable advanced imaging workflows, photostimulation, online analysis, and custom microscope control. Vidrio Technologies was acquired by MBF Bioscience in 2021 and now operates as part of the MBF Bioscience family, with its legacy site serving mainly technical support and product transition functions. The business is commercial-stage and oriented toward enabling biological discovery rather than developing therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vidrio Technologies.